Related Experiment Video

Updated: Sep 21, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

[Restrictive cardiomyopathy due to myofibrillar myopathy]

I Ligi1, A Fraisse, B Chabrol

  • 1Service de cardiologie pédiatrique, hôpital de la Timone-Enfant, 13005 Marseille, France.

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|July 25, 2003
PubMed

Insights

Early and severe cardiomyopathy in children may indicate myofibrillar myopathy. Diagnosis requires examining muscle biopsy samples, as seen in a fatal case of restrictive cardiomyopathy.

Area of Science:

  • Pediatric Cardiology
  • Neuromuscular Disorders
  • Genetic Pathology

Background:

  • Restrictive cardiomyopathy in infants presents diagnostic challenges.
  • Myofibrillar myopathies are a group of inherited muscle diseases.
  • Early diagnosis is crucial for managing pediatric cardiomyopathies.

Observation:

  • A one-year-old child presented with severe restrictive cardiomyopathy.
  • Muscle and endomyocardial biopsies confirmed myofibrillar myopathy.
  • The patient's condition was fatal despite intensive medical support.

Findings:

  • Myofibrillar myopathy can manifest as early and severe cardiomyopathy in children.
  • Biopsy analysis is essential for diagnosing myofibrillar myopathy.
  • Restrictive cardiomyopathy in pediatric cases warrants consideration of myofibrillar myopathy.

Implications:

  • Myofibrillar myopathy should be investigated in pediatric restrictive cardiomyopathy cases.
  • Diagnostic protocols for pediatric cardiomyopathy should include muscle biopsy.
  • Understanding the link between myofibrillar myopathy and cardiomyopathy may improve early detection and management.
Abstract

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...